The desirability and feasibility of economic studies of drugs post-launch.
Michael
M
Drummond
Anne
A
Mason
Adrian
A
Towse
D003362:Cost-Benefit Analysis; D017277:Drug Approval / Q000191:economics*; D017850:Economics, Pharmaceutical; D006801:Humans; D017059:Models, Econometric